0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Dermatologic Immunotherapy

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab
Yong He, MD; Michiko Shimoda, PhD; Yoko Ono, MD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Continued Learning  | 
A Patient With an Allergy Emergency
Steven M. Houser, MD; Catherine Weng, MD; Yi-Chun Liu, MD
JAMA Dermatology
The Cutting Edge  | 
IgE-Specific Immunoadsorption for Treatment of Recalcitrant Atopic Dermatitis
Michael Kasperkiewicz, MD; Sven Süfke, MD; Enno Schmidt, MD, PhD; et al.
JAMA Dermatology
Original Investigation  | 
Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol
Kara Heelan, MB, BCh, BAO, MRCPI; Faisal Al-Mohammedi, MD, FRCPC; Myles J. Smith, MB, BCh, BAO, FRCSI; et al.